Substance
REVUMENIB CITRATE
Global reference: every product and company linked to this substance.
- cas: 2761046-45-9
- ncit: C204149
- unii: YL4RYN734D
REVUFORJ · REVUMENIB CITRATE [USAN] · Revumenib citrate [WHO-DD]
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| SYNDAX PHARMACEUTICALS INC. COMMON STOCK | REVUFORJ | Q3 2025 | $32.0M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (1)
- REVUFORJ · SYNDAX PHARMACEUTICALS INC. COMMON STOCK